首页 | 本学科首页   官方微博 | 高级检索  
检索        

雷帕霉素药物洗脱支架置入前后稳定型心绞痛患者血清CXC趋化因子16的变化
引用本文:秦立,陈魁,何飞,姚友杰,姜正明,霍志芳,赵国鲜.雷帕霉素药物洗脱支架置入前后稳定型心绞痛患者血清CXC趋化因子16的变化[J].中国临床康复,2011(34):6319-6321.
作者姓名:秦立  陈魁  何飞  姚友杰  姜正明  霍志芳  赵国鲜
作者单位:郑州大学第一附属医院心血管内科,河南省郑州市450052
摘    要:背景:CXC趋化因子16作为一种炎症反应中的趋化因子冠状动脉粥样硬化发生机制中发挥重要作用。目的:观察雷帕霉素药物洗脱支架置入前后稳定型心绞痛患者血清中CXC趋化因子16的变化。方法:选择郑州大学第一附属医院心内科住院行冠状动脉支架置入并置入1或2枚雷帕霉素药物洗脱支架的稳定型心绞痛患者40例,另选同期于本院经冠状动脉造影显示无异常的健康者10名作为对照组。对受试者进行CXC趋化因子16、超敏C-反应蛋白检测,并分析其相互关系。结果与结论:与对照组相比,血清CXC趋化因子16在支架置入前、置入后0.5,2,24h均升高(P〈0.05);与置入前相比,置入后0.5,2h升高(P〈0.01)。置入后0.5,2,24h患者血清超敏C-反应蛋白较对照组显著升高(P〈0.01),其中置入后0.5h与2h差异无显著性意义(P〉0.05),2h高于24h(P〈0.01)。血清CXC趋化因子16和超敏C-反应蛋白水平呈正相关性(r=0.632,P=0.017)。

关 键 词:稳定型心绞痛  冠状动脉支架置入  雷帕霉素药物洗脱支架  CXC趋化因子16  超敏C-反应蛋白

Changes of serum CXC-chemokine ligand 16 in stable angina pectoris patients before and after implantation with rapamycin eluting stent
Qin Li,Chen Kui,He Fei,Yao You-jie,Jiang Zheng-ming,Huo Zhi-fang,Zhao Guo-xian.Changes of serum CXC-chemokine ligand 16 in stable angina pectoris patients before and after implantation with rapamycin eluting stent[J].Chinese Journal of Clinical Rehabilitation,2011(34):6319-6321.
Authors:Qin Li  Chen Kui  He Fei  Yao You-jie  Jiang Zheng-ming  Huo Zhi-fang  Zhao Guo-xian
Institution:Department of Cardiology,the First Affiliated Hospital,Zhengzhou University,Zhengzhou 450052,Henan Province,China
Abstract:BACKGROUND:CXC-chemokine ligand 16(CXCL16) is an important chemokine involved in inflammatory reaction,and plays a key role in the occurrence of coronary atherosclerosis. OBJECTIVE:To investigate the changes of serum CXCL16 in stable angina pectoris(SAP) patients who were implanted with rapamycin eluting stent. METHODS:Forty SAP patients were selected from the Department of Cardiology,the First Affiliated Hospital of Zhengzhou University. They underwent implantation of one or two rapamycin eluting stents. Another 10 health persons confirmed by coronary angiography were selected as controls. Serum CXCL16 and high-sensitivity C-reactive protein(Hs-CRP) were studied in all the subjects. RESULTS AND CONCLUSION:Compared with the control group,the serum CXCL16 showed higher levels in SAP patients prior to stent implantation and 0.5,2,24 hours after stent implantation(P 0.05);the serum CXCL16 level increased at 0.5 and 2 hours after stent implantation compared with before stent implantation(P 0.01) . At 0.5,2 and 24 hours after stent implantation,the levels of Hs-CRP in the SAP group were significantly higher than those in the control group(P 0.01);no significant difference in Hs-CRP levels was found(P 0.05) ,while the level of Hs-CRP at 2 hours was higher than that at 24 hours(P 0.05) . Serum CXCL16 is positively correlated with Hs-CRP(r=0.632,P=0.017).
Keywords:
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号